Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Singapore Translational Cancer Consortium will NEVER ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure something is a scam or visit ScamShield for more information

Singapore Translational Cancer Consortium (STCC)

Associate Professor David Tan

Business Intelligence and Development Clinical Lead

Last updated 30 June 2026
Associate Professor David Tan, Business Intelligence and Development Clinical Lead, STCC

Affiliations

  • Business Intelligence and Development Platform Lead, Singapore Translational Cancer Consortium

  • Senior Consultant, Department of Haematology-Oncology, National University Cancer Institute, Singapore

  • Senior Consultant, Department of Oncology - Medical & Radiation, Ng Teng Fong General Hospital

  • Associate Professor, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore

Profile

Dr David Tan is a medical oncologist and clinician scientist at the National University Cancer Institute, Singapore. He is an Associate Professor at the Yong Loo Lin School of Medicine, NUS and Principal Investigator at the Cancer Science Institute, NUS. He is also Head of the Innovation Transfer Office at National University Health Systems (NUHS). His primary clinical and research interests are in gynaecological (ovarian, endometrial and cervical) cancers and the development of novel anti-cancer therapeutic agents.

Dr Tan graduated from Guy’s, King’s and St Thomas’ School of Medicine, University of London, UK with a BSc in Experimental Pathology (1st Class Honours) and MBBS with Distinction. He undertook training in internal medicine at Hammersmith Hospital and Guy’s and St Thomas’ Hospitals in London before being awarded a Cancer Research UK Research Fellowship at The Institute of Cancer Research in London, where he obtained his PhD in Oncology. He subsequently completed his specialist training in medical oncology at The Royal Marsden Hospital in London. After working in the Drug Development Unit at The Royal Marsden Hospital/ Institute of Cancer Research, he completed another fellowship at the Princess Margaret Cancer Centre, University of Toronto, Canada, in Drug Development and Gynaecologic Oncology before returning back to Singapore.

He is the founding President of the Gynecologic Cancer Group Singapore (GCGS), which is a national clinical trials network for gynaecologic cancers in Singapore, and was the inaugural Chairman of the Asia-Pacific Gynaecologic Oncology Trials (APGOT) Group from 2019-2022. He currently also co-chairs the Cervical Cancer Research Network (CCRN) of the Gynecologic Cancer InterGroup (GCIG) and sits on the Gynecologic Cancer InterGroup (GCIG) Executive Board of Directors.